A distinctive acral erythema developed in four patients with myelogenous leukemia, subsequent to blood transfusions and intensive chemotherapy with cytarabine. The clinical and histopathologic features of the eruption were suggestive of a drug-induced toxic eruption. To our knowledge, only one previous similar case has been reported in the literature. For patients in whom this self-limited condition develops, reassurance should serve as the mainstay of therapy.
No takes yet. Share an insight, caveat, or question.
Lawrence E. Levine (1985) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: